Iskra Reic has held a variety of leadership roles in her 23 years at AstraZeneca. As the executive vice president of the vaccines and immune therapies unit, she oversees the global vaccines and immune therapies pipeline and portfolio. She has a PhD in strategy and leadership and an international executive MBA in business and leadership from the IEDC-Bled School of Management.